High plasma endothelin-1 levels in hypertensive patients with low-renin essential hypertension

Journal of Human Hypertension

Volumn 11, Issue 7, 1997, Pages 447-451

  Letizia, C ^a,b   Cerci, S ^a   De Toma, G ^a   D'Ambrosio, C ^a   De Ciocchis, A ^a   Coassin, S ^a   Scavo, D ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Endothelin 1; Essential hypertension; Renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ENDOTHELIN 1; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; PLASMA RENIN ACTIVITY; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030763714     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000454     Document Type: Article

References (30)

1. Yanagisawa M et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
2. Masaki T, Kimura S, Yanagisawa N, Goto K. Molecular and cellular mechanism of endothelin regulation: implications for vascular function. Circulation 1991; 84: 1457-1468.
3. Saito Y, Nakao K, Mukoyama M, Imura M. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 322: 205.
4. Shichiri N et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493-496.
5. Kohno M et al. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88: 614-618.
6. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4: 303-308.
7. Davenport AP et al. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990; 78: 261-264.
8. Letizia C et al. Plasma endothelin-1 levels in normotensive and borderline hypertensive subjects during a standard cold pressor test. J Hum Hypertens 1995; 9: 903-907.
9. Yoshizumi M et al. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989; 161: 859-864.
10. Yokokawa K et al. Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med 1991; 114: 213-215.
11. Miller LW, Redfield MM, Burnett JC. Integrated cardiac, renal and endocrine action of endothelin. J Clin Invest 1989; 83: 317-320.
12. Goetz KL et al. Cardiovascular renal and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 1988; 255: 1064-1068.
13. Takaji M, Matsuoka H, Atarashi K, Yagi S. Endothelin: A new inhibitor of renin release. Biochem Biophis Res Commun 1988; 157: 1164-1168.
14. Rakugi H et al. Endothelin inhibits renin release from isolated rat glomeruli. Biochem Biophis Res Commun 1988; 155: 1244-1247.
15. Morishita R, Higaki J, Ogihara T. Endothelin stimulates aldosterone biosynthesis by dispersed rabbit adrenocapsular cells, Biochem Biophis Res Commun 1989; 160: 628-632.
16. Cozza EN, Gomez-Sanchez CE, Foeking MF, Chiou S. Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest 1989; 84: 1032-1035.
17. Laragh JH et al. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 1972; 52: 633-652.
18. Laragh JH. Role of the renin-angiotensin-aldosterone axis in human hypertensive disorders. In: Kaplan N, Brenner B, Laragh JH (eds). The kidney in hypertension. Raven Press: New York, NY, 1987, pp 35-51.
19. Laragh JH, Sealey JE, Niarchos AP, Pickering TG. The vasoconstriction-volume spectrum in normotension and pathogenesis of hypertension. Fed Proc 1982; 41: 2415-2423.
20. Haber E et al. Application of radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 1969; 29: 1349-1353.
21. McKenzie JK, Clements JA. Simplified radioimmunoassay for serum for serum aldosterone utilizing increased antibody specificity. J Clin Endocrinol Metab 1974; 36: 622-625.
22. Letizia C et al. Dynamic exercise induces elevation of plasma levels of endothelin-1 in patients with coronary artery disease. Angiology 1995; 46: 819-826.
23. Ando K et al. Presence of immunoreactive endothelin in human plasma. Febs Lett 1989; 245: 164-166.
24. Naruse M et al. Plasma immunoreactive endothelin, but not thrombomodulin, is increased in patients with essential hypertension and ischemic heart disease. J Cardiovasc Pharmacol 1991; 17 (Suppl 7): S471-S474.
25. Shichiri M et al. Effects of endothelin on the release of vasopressin from perfused rat hypothalamus. Biochem Biophys Res Commun 1989; 163: 1332-1337.
26. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr. Endothelin has biological actions at pathophysiological concentrations. Circulation 1991; 83: 1808-1814.
27. Vierhapper H, Wagner O, Nowotny P, Waldhaus W. Effect of endothelin in man. Circulation 1990; 81: 1415-1418.
28. Komuro I et al. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular. Febs Lett 1988; 238: 249-252.
29. Mortensen LH, Fink GD. Captopril prevents chronic hypertension produced by infusion of endothelin-1 in rats. Hypertension 1990; 19: 676-680.
30. Cozza EN, Chiou S, Gomez-Sanchez CE. Endothelin-1 potentiation of angiotensin II stimulation of aldosterone production. Am J Physiol 1992; 262: 285-289.